Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 2/2017

17-08-2016

Recent viral infection in US blood donors and health-related quality of life (HRQOL)

Auteurs: Farnaz Vahidnia, Susan L. Stramer, Debra Kessler, Beth Shaz, German Leparc, David E. Krysztof, Simone A. Glynn, Brian Custer

Gepubliceerd in: Quality of Life Research | Uitgave 2/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Blood donors are considered to be one of the healthiest populations, but relatively little is known about their perceived quality of life. The objective was to examine HRQOL in donors infected with HIV, HBV, HCV or HTLV and a comparison group.

Methods

Donors with confirmed viral infection (cases) and donors who tested false-positive (controls) participated in a multicenter study of US blood donors (2010–2013), funded by the National Heart, Lung and Blood Institute (NHLBI). HRQOL was measured by the EuroQol Five Dimension (EQ-5D) instrument and EQ-5D visual analogue scale (VAS). The lower 25th ‰ of EQ-5D index or VAS score of controls was defined as a “lower HRQOL.”

Results

A total of 1574 controls completed the HRQOL assessment with a mean EQ-5D index of 0.94 (SD = 0.10) and EQ-VAS of 87.6 (SD = 10.6). Mean EQ-5D index for 192 HIV-, 315 HCV- and 195 HTLV-positive donors were significantly lower than the controls (0.86, 0.83 and 0.87; SD = 0.18, 0.20 and 0.16, respectively, p < 0.001). HBV-positive donors (n = 290) had a similar mean EQ-5D index (0.93, SD = 0.14, p = 0.05) to controls. Anxiety/depression was reported by 34 % of cases, compared with 13 % of controls. In multivariable modeling, the odds of lower HRQOL in HIV, HBV, HCV and HTLV cases were 2.1, 1.6, 2.6 and 2.3 times that of controls, respectively (p < 0.05).

Conclusions

HRQOL reported by blood donors with recent viral infections was relatively high but lower than controls. On average, HRQOL among HCV-positive donors was the lowest and HBV-positive donors reported scores similar to donors without infection.
vorige artikel Mortality risk and perceived quality of life as a function of waking time in discretionary movement-based behaviors: isotemporal substitution effects
volgende artikel Self-management behavior among patients with diabetic retinopathy in the community: a structural equation model
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
2.
Centers for Disease Control and Prevention (CDC). (1991). Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR, 40(RR-4), 1–17.
3.
4.
Brown, L. K., Whiteley, L., Harper, G. W., Nichols, S., Nieves, A., & Protocol Team for The Adolescent Medicine Trials Network for HIV/AIDS Interventions. (2015). Psychological symptoms among 2032 youth living with HIV: A multisite study. AIDS Patient Care STDS, 29(4), 212–219.CrossRefPubMedPubMedCentral
5.
Honiden, S., Sundaram, V., Nease, R. F., Holodniy, M., Lazzeroni, L. C., Zolopa, A., et al. (2006). The effect of diagnosis with HIV infection on health-related quality of life. Quality of Life Research, 15(1), 69–82.CrossRefPubMed
6.
Rodger, A. J., Jolley, D., Thompson, S. C., Lanigan, A., & Crofts, N. (1999). The impact of diagnosis of hepatitis C virus on quality of life. Hepatology, 30(5), 1299–1301.CrossRefPubMed
7.
Stasi, C., Silvestri, C., Voller, F., & Cipriani, F. (2015). The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. Journal of Infection and Public Health, 9(4), 389–395.CrossRefPubMed
8.
Atsma, F., Veldhuizen, I., Verbeek, A., de Kort, W., & de Vegt, F. (2011). Healthy donor effect: Its magnitude in health research among blood donors. Transfusion, 51(8), 1820–1828.CrossRefPubMed
9.
Edgren, G., Tran, T. N., Hjalgrim, H., Rostgaard, K., Shanwell, A., Titlestad, K., et al. (2007). Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion, 47(11), 2017–2024.CrossRefPubMed
10.
Shehu, E., Hofmann, A., Clement, M., & Langmaack, A. C. (2015). Healthy donor effect and satisfaction with health: The role of selection effects related to blood donation behavior. The European Journal of Health Economics, 16(7), 733–745.CrossRefPubMed
11.
Ullum, H., Rostgaard, K., Kamper-Jorgensen, M., Reilly, M., Melbye, M., Nyren, O., et al. (2015). Blood donation and blood donor mortality after adjustment for a healthy donor effect. Transfusion, 55(10), 2479–2485.CrossRefPubMed
12.
Guiltinan, A. M., Murphy, E. L., Horton, J. A., Nass, C. C., McEntire, R. L., & Watanabe, K. (1998). Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus epidemiology donor study. Transfusion, 38(11–12), 1056–1062.PubMed
13.
Kanwal, F., Gralnek, I. M., Martin, P., Dulai, G. S., Farid, M., & Spiegel, B. M. (2005). Treatment alternatives for chronic hepatitis B virus infection: A cost-effectiveness analysis. Annals of Internal Medicine, 142(10), 821–831.CrossRefPubMed
14.
Ong, S. C., Mak, B., Aung, M. O., Li, S. C., & Lim, S. G. (2008). Health-related quality of life in chronic hepatitis B patients. Hepatology, 47(4), 1108–1117.CrossRefPubMed
15.
Woo, G., Tomlinson, G., Yim, C., Lilly, L., Therapondos, G., Wong, D. K., et al. (2012). Health state utilities and quality of life in patients with hepatitis B. Canadian Journal of Gastroenterology and Hepatology, 26(7), 445–451.
16.
El Khoury, A. C., Vietri, J., & Prajapati, G. (2012). The burden of untreated hepatitis C virus infection: A US patients’ perspective. Digestive Diseases and Sciences, 57(11), 2995–3003.CrossRefPubMed
17.
Spiegel, B. M., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005). Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology, 41(4), 790–800.CrossRefPubMed
18.
Whiteley, D., Elliott, L., Cunningham-Burley, S., & Whittaker, A. (2015). Health-related quality of life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy, 26(10), 936–949.CrossRefPubMed
19.
Carvalho, A. G., Galvao-Phileto, A. V., Lima, N. S., Jesus, R. S., Galvao-Castro, B., & Lima, M. G. (2009). Frequency of mental disturbances in HTLV-1 patients in the state of Bahia, Brazil. Brazilian Journal of Infectious Diseases, 13(1), 5–8.CrossRefPubMed
20.
Guiltinan, A. M., Kaidarova, Z., Behan, D., Marosi, C., Hutching, S., Kaiser, M., et al. (2013). Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors. Transfusion, 53(1), 60–68.CrossRefPubMed
21.
Gillis, J., Cooper, C., Rourke, S., Rueda, S., O’Brien, K., Collins, E., et al. (2013). Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Quality of Life Research, 22(7), 1525–1535.CrossRefPubMed
22.
Kanwal, F., Gralnek, I. M., Hays, R. D., Dulai, G. S., Spiegel, B. M., Bozzette, S., et al. (2005). Impact of chronic viral hepatitis on health-related quality of life in HIV: Results from a nationally representative sample. American Journal of Gastroenterology, 100(9), 1984–1994.CrossRefPubMed
23.
Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed
24.
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.CrossRefPubMed
25.
Johnson, J. A., & Pickard, A. S. (2000). Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Medical Care, 38(1), 115–121.CrossRefPubMed
26.
27.
Custer, B., Kessler, D., Vahidnia, F., Leparc, G., Krysztof, D. E., Shaz, B., et al. (2015). Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion, 55(5), 1098–1107.CrossRefPubMed
28.
Sharma, U. K., Stramer, S. L., Wright, D. J., Glynn, S. A., Hermansen, S., Schreiber, G. B., et al. (2003). Impact of changes in viral marker screening assays. Transfusion, 43(2), 202–214.CrossRefPubMed
29.
Custer, B., Kamel, H., Kiely, N. E., Murphy, E. L., & Busch, M. P. (2009). Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion, 49(2), 278–288.CrossRefPubMed
30.
The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
31.
Oemar, M., & Oppe, M. (2013). EQ-5D-3L user guide, basic information on how to use the EQ-5D-3L instrument (5.0th ed.). The Netherlands: EuroQoL Group.
32.
Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRefPubMed
33.
Revicki, D. A. (1992). Relationship between health utility and psychometric health status measures. Medical Care, 30(5 Suppl), MS274–MS282.PubMed
34.
Ferreira, F. A., de Almeida-Neto, C., Teixeira, M. C., & Strauss, E. (2015). Health-related quality of life among blood donors with hepatitis B and hepatitis C: Longitudinal study before and after diagnosis. Revista Brasileira de Hematologia e Hemoterapia, 37(6), 381–387.CrossRefPubMedPubMedCentral
35.
McAuley, J. D., Caglioti, S., Williams, R. C., Robertson, G. F., Morgan, L., Tobler, L. H., et al. (2004). Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay. Transfusion, 44(1), 91–96.CrossRefPubMed
36.
Vahidnia, F., Stramer, S. L., Kessler, D., Goncalez, T. T., Shaz, B. H., Leparc, G., et al. (2016). Motivations for donating and attitudes toward screening policies in US blood donors with viral infection. Transfusion, 56(8), 2013–2020.CrossRefPubMed
37.
Tillmann, H. L., Wiese, M., Braun, Y., Wiegand, J., Tenckhoff, S., Mossner, J., et al. (2011). Quality of life in patients with various liver diseases: Patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment. Journal of Viral Hepatitis, 18(4), 252–261.CrossRefPubMed
38.
Helbling, B., Overbeck, K., Gonvers, J. J., Malinverni, R., Dufour, J. F., Borovicka, J., et al. (2008). Host-rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, 57(11), 1597–1603.CrossRefPubMed
39.
Rowan, P. J., Al-Jurdi, R., Tavakoli-Tabasi, S., Kunik, M. E., Satrom, S. L., & El-Serag, H. B. (2005). Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. Journal of Clinical Gastroenterology, 39(8), 731–736.CrossRefPubMed
40.
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2095–2128.CrossRefPubMed
41.
42.
43.
Brazier, J., Jones, N., & Kind, P. (1993). Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Quality of Life Research, 2(3), 169–180.CrossRefPubMed
Metagegevens
Titel
Recent viral infection in US blood donors and health-related quality of life (HRQOL)
Auteurs
Farnaz Vahidnia
Susan L. Stramer
Debra Kessler
Beth Shaz
German Leparc
David E. Krysztof
Simone A. Glynn
Brian Custer
Publicatiedatum
17-08-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 2/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1392-5

Andere artikelen Uitgave 2/2017

Quality of Life Research 2/2017 Naar de uitgave

OriginalPaper

Measurement equivalence of the Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Medicare survey items between Whites and Asians

OriginalPaper

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L)

OriginalPaper

Expectations of younger patients concerning activities after knee arthroplasty: are we asking the right questions?

OriginalPaper

Long-term effects of a dyadic psycho-educational intervention on caregiver burden and morbidity in partners of patients with heart failure: a randomized controlled trial

OriginalPaper

Quality of life of pediatric oncology patients: Do patient-reported outcome instruments measure what matters to patients?

OriginalPaper

The challenge of measuring intra-individual change in fatigue during cancer treatment